Theron Pharmaceuticals
Sunnyvale, California, United States
About Theron Pharmaceuticals
Theron Pharmaceuticals is a biotechnology company that develops long-acting M3 muscarinic antagonist (LAMA) products for the treatment of chronic respiratory diseases. Its TRN-157 is a preclinical development program that focuses on the treatment of chronic obstructive pulmonary disease and severe asthma. The company was founded in 2008 and is based in Sunnyvale, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $2.2M
- Last round: Series Unknown (Aug 2015)
- Website: theronpharma.com
- Phone: 408-792-7424
Industries & Categories
Biotechnology, Developer Platform, Health Care, Therapeutics
Canonical: https://fsome.com/organization/theron-pharmaceuticals-2480273 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.